Dutasteride soft capsules for benign prostatic hyperplasia (BPH): efficacy and dosage
Dutasteride soft capsules significantly improve the symptoms of benign prostatic hyperplasia by inhibiting 5 α - reductase. The standard dose is 0.5mg per day, and continuous use for 6 months is required to achieve maximum efficacy. The following provides a detailed explanation from four aspects: mechanism of action, clinical efficacy, medication plan, and precautions.
1. Mechanism of action
(1) Double effect inhibition: Simultaneously inhibiting type I and type II 5 α - reductase, reducing dihydrotestosterone levels by more than 90%.
(2) Organizational improvement: Reduce prostate volume by 20-30% and alleviate symptoms of urethral compression.
2. Clinical efficacy
(1) Symptom relief: After 3 months of medication, the International Prostate Symptom Score (IPSS) decreased by an average of 4.5 points.
(2) Urinary flow improvement: the maximum urinary flow rate increased by 1.5-2.0 mL/s, reducing the risk of acute urinary retention by 57%.
3. Medication plan
(1) Standard dose: Take 0.5mg orally at a fixed time daily without adjustment with meals.
(2) Treatment requirements: Evaluate the efficacy of continuous use for at least 6 months, and long-term maintenance treatment can prevent progression.
4. Important precautions
(1) Delayed onset: Symptom improvement takes 2-4 weeks, and complete effect may take 6-12 months.
(2) Dose warning: Overdose use is prohibited. Exceeding 0.5mg per day will not enhance efficacy but increase side effects.
(3) Special monitoring: PSA and liver function indicators should be regularly checked before and during medication.
Disclaimer：《Dutasteride soft capsules for benign prostatic hyperplasia (BPH): efficacy and dosage》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！